Nicotinamide mononucleotide impacts HIV-1 infection by modulating immune activation in T lymphocytes and humanized mice
Yufei Mo,Ming Yue,Lok Yan Yim,Runhong Zhou,Chunhao Yu,Qiaoli Peng,Ying Zhou,Tsz-Yat Luk,Grace Chung-Yan Lui,Huarong Huang,Chun Yu Hubert Lim,Hui Wang,Li Liu,Hongzhe Sun,Jun Wang,Youqiang Song,Zhiwei Chen
DOI: https://doi.org/10.1016/j.ebiom.2023.104877
IF: 11.205
2023-12-01
EBioMedicine
Abstract:BACKGROUND: HIV-1-associated immune activation drives CD4<sup>+</sup> T cell depletion and the development of acquired immunodeficiency syndrome. We aimed to determine the role of nicotinamide mononucleotide (NMN), the direct precursor of nicotinamide adenine dinucleotide (NAD) co-enzyme, in CD4<sup>+</sup> T cell modulation during HIV-1 infection.METHODS: We examined HIV-1 integrated DNA or transcribed RNA, intracellular p24 protein, and T cell activation markers in CD4<sup>+</sup> T cells including in vitro HIV-1-infected cells, reactivated patient-derived cells, and in HIV-1-infected humanized mice, under NMN treatment. RNA-seq and CyTOF analyses were used for investigating the effect of NMN on CD4<sup>+</sup> T cells.FINDINGS: We found that NMN increased the intracellular NAD amount, resulting in suppressed HIV-1 p24 production and proliferation in infected CD4<sup>+</sup> T cells, especially in activated CD25<sup>+</sup>CD4<sup>+</sup> T cells. NMN also inhibited CD25 expression on reactivated resting CD4<sup>+</sup> T cells derived from cART-treated people living with HIV-1 (PLWH). In HIV-1-infected humanized mice, the frequency of CD4<sup>+</sup> T cells was reconstituted significantly by combined cART and NMN treatment as compared with cART or NMN alone, which correlated with suppressed hyperactivation of CD4<sup>+</sup> T cells.INTERPRETATION: Our results highlight the suppressive role of NMN in CD4<sup>+</sup> T cell activation during HIV-1 infection. It warrants future clinical investigation of NMN as a potential treatment in combination with cART in PLWH.FUNDING: This work was supported by the Hong Kong Research Grants Council Theme-Based Research Scheme (T11-706/18-N), University Research Committee of The University of Hong Kong, the Collaborative Research with GeneHarbor (Hong Kong) Biotechnologies Limited and National Key R&D Program of China (Grant2021YFC2301900).
medicine, research & experimental